Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Experimental and Applied Biomedical Research (EABR)
Volume 20 (2019): Issue 2 (June 2019)
Open Access
Atherogenic Impact of Homocysteine: Can
HMG-CoA
Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?
Tamara Nikolic
Tamara Nikolic
,
Ivan Srejovic
Ivan Srejovic
,
Isidora Stojic
Isidora Stojic
,
Jovana Jeremic
Jovana Jeremic
,
Marko Folic
Marko Folic
,
Stevan Matic
Stevan Matic
,
Milena Rakocevic
Milena Rakocevic
,
Snezana Jancic
Snezana Jancic
,
Biljana Jakovljevic
Biljana Jakovljevic
,
Radmila Obrenovic
Radmila Obrenovic
,
Dusan Djuric
Dusan Djuric
and
Vladimir Zivkovic
Vladimir Zivkovic
| Jul 30, 2019
Experimental and Applied Biomedical Research (EABR)
Volume 20 (2019): Issue 2 (June 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jul 30, 2019
Page range:
37 - 46
Received:
Oct 17, 2017
Accepted:
Oct 23, 2017
DOI:
https://doi.org/10.1515/sjecr-2017-0055
Keywords
atherogenic index
,
hyperhomocysteinaemia
,
liver
,
HMG-CoA reductase inhibitors
© 2019 Tamara Nikolic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.